Advertisement
U.S. markets closed

The Chemours Company (CC)

NYSE - NYSE Delayed Price. Currency in USD
26.26-2.62 (-9.07%)
At close: 04:01PM EDT
26.05 -0.21 (-0.80%)
After hours: 07:48PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close28.88
Open25.00
Bid26.33 x 1100
Ask26.38 x 900
Day's Range24.24 - 27.40
52 Week Range15.10 - 39.05
Volume6,319,618
Avg. Volume2,026,373
Market Cap3.898B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.00
Earnings DateApr 25, 2024 - Apr 29, 2024
Forward Dividend & Yield1.00 (3.46%)
Ex-Dividend DateFeb 23, 2024
1y Target Est29.22
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
-0% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Chemours Company (The)
    Analyst Report: Chemours CompanyChemours, a July 2015 spinoff from DuPont, is a global leader in titanium technologies, fluoroproducts, and chemical solutions. Its products are used in a wide range of industrial businesses, including plastics, coatings, refrigeration and air conditioning, mining, and oil refining. Its major brands include Teflon, Ti-Pure, Krytox, Viton, Opteon, Freon and Nafion. The company is based in Wilmington, Delaware. It has 6,600 employees. The CC shares are a component of the S&P 400 Index.
    Rating
    Fair Value
    Economic Moat
    18 days agoArgus Research
View more
  • Thomson Reuters StreetEvents

    Q4 2023 Chemours Co Earnings Call

    Q4 2023 Chemours Co Earnings Call

  • ACCESSWIRE

    Chemours Brings a Unique Voice to Global Energy Conference, CERAWeek

    From hydrogen to energy hungry data centers, chemistry is essential to solving the biggest challenges NORTHAMPTON, MA / ACCESSWIRE / March 28, 2024 / Last week, Chemours was on the ground in Houston, Texas for CERAWeek. Held annually, CERAWeek is ...

  • Reuters

    Chemours falls on weak quarterly sales forecast after internal review

    The review identified "material weaknesses" in its internal control over financial reporting and resulted in revisions of its balance sheet as of Dec. 31, 2022, and its cash flow statements for 2021 and 2022. In its twice-delayed results announcement, Chemours forecast first-quarter net sales to be flat to down sequentially and capital expenditures of about $100 million. It also forecast a 10% sequential decline in net sales for the titanium technologies segment due to seasonally weak demand for titanium, along with a drop in sales in its advanced performance materials segment.